In summary, the findings indicate that combined anti–PD-L1 and AFP immunization increased activated CD8+ T cells, including AFP499+ CTLs, inducing the dramatic inhibition of most tumor lesions in c-MYC/Mcl1 mice. The gene discussed is CD8A; the disease is neoplasm.